Our Diabetology Network is under Biotechnology Industry Research Assistance Council (BIRAC) a not-for-profit Section 8, Schedule B, Public Sector Enterprise, set up by NBM, Department of Biotechnology (DBT), Government of India as an Interface Agency to strengthen and empower the emerging Biotech enterprise to undertake strategic research and innovation, addressing nationally relevant product development needs.
BIRAC is an industry-academia interface and implements its mandate through a wide range of impact initiatives, be it providing access to risk capital through targeted funding, technology transfer, IP management and handholding schemes that help bring innovation excellence to the biotech firms and make them globally competitive.
The Request for proposal from BIRAC to establish Clinical Trial Network for hospital based trial in specialties of Diabetology, Ophthalmology, Rheumatology and Oncology was announced in August 2019
The site selection was done in different geographical locations across India to establish PAN INDIA NETWORK with pool of both Private & Government organisation and blend of experienced and in-experienced sites
Received proposals from nine speciality hospitals in which 7 sites were finalized to formulate the CTN Diabetology
The CTN Diabetology Network has received grant of 11.26 crores, having its lead site at M S Ramaiah Medical College and Hospitals-which is ranked 30th amongst all the Medical Colleges in India by NIRF
The project duration to be completed within stipulated period of 36 months from the date of acceptance of GLA by all the recipients
The project kicked off in 6th Jul 2020 with timeline till 06th July 2023
The objectives finalized for the CTN Diabetology are: